NEW YORK (GenomeWeb News) – French genome engineering company Cellectis said yesterday that it will collaborate with the French National Institute for Agricultural Research, or INRA, to investigate the use of Cellectis' technology in a range of applications.

Under the five-year, non-exclusive agreement, Cellectis and INRA will investigate the potential of a range of technologies in which Cellectis specializes, including reverse genetics, homologous recombination, and gene targeting, in applications such as cell biology and plant and animal biotechnology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."